Martorell et al. suggested that the therapeutic effects of emodin on diabetes include reducing the production of inflammatory cytokines, increasing insulin secretion, and improving insulin sensitivity (Martorell et al., 2021). This evidence concerns the gene INS and diabetes mellitus.